Scientific Sessions 2024  /  From Intervention to Prevention: Advances in Coronary and Valvular Heart Disease  /  Discussant: CLEAR SYNERGY
Logo

American Heart Association

  156
  0

Final ID:

Discussant: CLEAR SYNERGY

  • Bonaca, Marc  ( CPC Clinical Research , Aurora , Colorado , United States )
    • Author Disclosures:
    Marc Bonaca: DO have relevant financial relationships ; Research Funding (PI or named investigator):Dr. Bonaca is the Executive Director of CPC:Active (exists now) ; Research Funding (PI or named investigator):Dr. Bonaca is the Executive Director of CPC:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

From Intervention to Prevention: Advances in Coronary and Valvular Heart Disease

Sunday, 11/17/2024 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:
the CLEAR SYNERGY (OASIS 9) Trial: A 2x2 Factorial Randomized Controlled Trial of Colchicine versus placebo and Spironolactone versus placebo in Patients with Myocardial Infarction. The results of the spironolactone factorial.

Jolly Sanjit

Discussant: GLORIOUS

Sandner Sigrid

More abstracts from these authors:
Making STRIDEs in diabetes: the role of incretin-based therapy in peripheral artery disease

Bonaca Marc, Verma Subodh

Antithrombotic prophylaxis in patients with peripheral arterial disease

Bonaca Marc, Creager Mark

You have to be authorized to contact abstract author. Please, Login
Not Available